Altimmune Market Cap

Altimmune has a market cap or net worth of $460.45 million as of March 6, 2026. Its market cap has decreased by -2.36% in one year.

Market Cap

460.45M

Enterprise Value

222.68M

1-Year Change

-2.36%

Ranking

#3097

Market Cap Chart

Since October 6, 2005, Altimmune's market cap has increased from $81.50M to $460.45M, an increase of 464.97%. That is a compound annual growth rate of 8.85%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	460.40M	22.32%
Dec 31, 2025	376.40M	-26.60%
Dec 31, 2024	512.80M	-15.16%
Dec 29, 2023	604.40M	-25.26%
Dec 30, 2022	808.70M	122.17%
Dec 31, 2021	364.00M	-2.41%
Dec 31, 2020	373.00M	1,186.21%
Dec 31, 2019	29.00M	61.11%
Dec 31, 2018	18.00M	-42.12%
Dec 29, 2017	31.10M	-85.66%
Dec 30, 2016	216.90M	77.06%
Dec 31, 2015	122.50M	6.80%
Dec 31, 2014	114.70M	17.88%
Dec 31, 2013	97.30M	79.52%
Dec 31, 2012	54.20M	-11.58%
Dec 30, 2011	61.30M	-64.57%
Dec 31, 2010	173.00M	210.59%
Dec 31, 2009	55.70M	-6.39%
Dec 31, 2008	59.50M	-31.77%
Dec 31, 2007	87.20M	1.04%
Dec 29, 2006	86.30M	4.10%
Dec 30, 2005	82.90M	1.72%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Rocket Pharmaceuticals	478.79M
Lyell Immunopharma	477.14M
Eupraxia Pharmaceuticals	473.55M
Atea Pharmaceuticals	469.27M
Vanda Pharmaceuticals	466.36M
Kyverna Therapeutics	462.75M
Century Therapeutics	459.90M
Entrada Therapeutics	452.88M

Market Cap Rankings